Astrocytoma
Magnetic resonance spectroscopy of oligodendroglial tumors aided cancer staging
Published in Cancer Weekly, August 23rd, 2005
"Oligodendroglial neoplasms with combined loss of chromosomes 1p and 19q may have a good prognosis and respond to procarbazine-lomustine (CCNU)-vincristine (PCV) chemotherapy." The scientists' goal was "to determine whether single voxel MRS (SV-MRS) obtained through routine clinical practice distinguishes between histopathologic and genetic subtypes of oligodendroglial tumors."
"Forty-eight patients with oligodendroglial tumors (19 oligodendrogliomas and 29 oligoastrocytomas) underwent molecular genetic analysis to determine allelic imbalance in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-08-23)
More Articles from Cancer Weekly
- Cancer Risk Factors
Cancer of gastrointestinal tract caused by asbestos in drinking water - Cancer Treatments
Quality of life during palliative chemotherapy for solid cancer kept intact - Gastric Cancer
Epidemiology of gastric cancer in Japan discussed - Prostate Cancer
Coping strategies for prostate cancer reviewed - Skin Cancer
Indoor UV tanning facilities encouraged to provide health risks information - Ampullary Cancer
Feasibility of ampullectomy for early ampullary cancers evaluated - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
